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Servings for daily dietary content (11e15 years).
Food category Services Protein
(g)
Leucine
(mg)
Fat
(g)
Carbohydrate
(g)
Calories
(kcal)
Vegetable 3 EXa 3 90 0 15 75
Fruit 2 EX 0.8 30 0 30 120
Rice, white
(cooked)
6 EX 9 692.3 0 90 420
Oil 6 EX 0 0 30 0 270
Low nitrogen 130 g 0 0 0 119 4823-Hydroxy-3-methylglutaric aciduria (OMIM 246450) is an
extremely rare genetic metabolic disorder of leucine caused by
deﬁciency of 3-hydroxy-3-methylglutaryl-CoA lyase (HMG-CoA
lyase). Affected patients present with life-threatening metabolic
acidosis, hyperammonemia, and nonketotic hypoglycemia. Optimal
outcome for patients depends on early diagnosis and treatment,
prompt management of acute metabolic decompensation during
the chronic stage, and long-term interprofessional health care
programs. Nutritionists play a pivotal role in the care of metabolic
disorders throughout the rest of a patient’s life.
A 4-year-old intubated Bunun tribe female patient was admitted
to the pediatric intensive care unit of the Buddhist Tzu Chi General
Hospital (Hualien, Taiwan) due to status epilepticus, hypoglycemia,
and severe metabolic acidosis. Results of urine gas chromatography
with mass spectrometry revealed markedly elevated 3-methyl-
glutaric acid, 3-hydroxy-3-methylglutaryl-CoA, and 3-hydroxy-
isovaleric acid, a ﬁnding consistent with a diagnosis of HMG-CoA
lyase deﬁciency. She received an interdisciplinary health care pro-
gram after acute management. Dietary therapy was the major part
of the transdisciplinary health delivery process.
Total daily calories were increased from 1400 kcal/day (targeted
60e80%) to 2100e2200 kcal/day (targeted 100%). The ratio of
protein lipid and carbohydrate was 13%:24%:63% as recommended
for healthy children. Lifelong protein restrictionwas essential. TotalConﬂicts of interest: none.
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http://dx.doi.org/10.1016/j.tcmj.2014.01.001daily protein was given at a dose of 1.5e2 g/kg/day (target: above
50 g/day after the age of 4 years) and was administered at different
growth and developmental stages. The daily leucine dose was
1000 mg (suggested dose ¼ 700e900 mg/day), 1.5% of the total
protein amount was designed for her. Because leucine is an
essential amino acid, close monitoring of optimal serum levels
through blood sampling should be reached for better growth and
development. Food avoidance was a major focus on restriction of
protein from milk, meat, cheese, ﬁsh, poultry (including egg),
beans, and nutlets, and even any foods containing milk and egg.
Partial limited foods included sprouts (alfalfa, clover), radish, red
bean, and murgbean. Unlimited fruits included vegetables and low
protein starch such as green bean noodles, rice ﬂour, pearl sago,
lotus root powder, cornstarch, and corn ﬂour, and low leucine foods
such as potato powder were advised. The patient’s major protein
source was from a special formula (I-Valex I and II; Abbott, Chicago,
USA). Other nutrients such as multivitamins and minerals were
prescribed. Daily oral L-carnitine was also prescribed to increase
excretion of organic acid. The ability to recognize food labeling was
taught to the parents, the patient, and school nurses. Servings for
daily dietary content (Table 1) and sample meal plans were
designed (Table 2).starch
I-Valex II 180 g 55 0 23.4 63 738
Total 67.8 825.3 53.4 317 2105
% 13 24 63
a EX ¼ exchange, each exchange list contains foods that are alike; each food
choice on a list contains about the same amount of carbohydrate, protein, fat, and
calories as the other choices on that list.
Foundation. Published by Elsevier Taiwan LLC. All rights reserved.
Table 2
One day’s meal plan for patient affected with leucine metabolic disorder.a
Solid food Soup and drink
Breakfast Vegetable sandwich with egg-free mayonnaise
sauce (two pieces of grilled toast packed with
50 g ﬁlamentous cabbage, sliced tomato, and
cucumber in small pieces)
Formula: 350 mL
(special formula
I-Valex II 60 g
mixed with
maltodextrin
30 g in 350 mL
water)
Snack Fruit: an apple, weight ¼ 130 g
Lunch 1. Fried rice (half bowl of cooked rice 100 g,
fried with 50 g carrots, onion, and mushroom)
2. Vegetable (celery 50 g with 20 g
konnyaku strips)
100 mL carrot and
white radish (30 g)
soup with parsley
Snack Pearl milk tea (special formula I-Valex II 60 g
mixed with maltodextrin 30 g in 350 mL water
and 40 g tapioca ball)
Dinner 1. White noodles with vegetable (40 g dry white
noodles cooked with 30 g fresh mushroom, 50 g
cabbage, and 20 g golden mushrooms)
2. Fruit: cantaloupe (mino) 165 g
Snack 350 mL formula milk (special formula I-Valex II
60 g mixed with maltodextrin 30 g in
350 mL water)
a This meal plan does not include total daily ﬂuid requirement.
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glycemia was also addressed to parents, school teachers, schoolnurses, and the patient. No episodes of metabolic decompensation
or hypoglycemia were noted during the past 9 years of follow-up.
Her growth and development were initially at the 25th percentile
and she grew steadily to the 50the75th percentiles as compared to
her peers.
The goal of dietary therapy is to maintain normal plasma amino
acid levels, avoid metabolic decompensation, and promote normal
growth and development. Dietary meal plans should be designed
and combined with special infant formula for treating patients
affected with congenital metabolic disorders.Further reading
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